Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1608404

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Migrant Workers
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how many international nurses NHS Trusts have recruited in the past 12 months; and of those, how many have been permitted to work.
tabling member printed	Baroness Cavendish of Little Venice
uin	HL6909
answer	answer is ministerial correction date of answer 06/04/2023 answer text <p>This information is not collected centrally.</p> answering member printed Lord Markham question first answered 06/04/2023 10:41:51 answering member 4948 label Biography information for Lord Markham
tabling member	4578 label Biography information for Baroness Cavendish of Little Venice

1608405

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Migrant Workers
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how many of the international nurses who arrived in the UK in the past 12 months have had an Objective Structured Clinical Examination; and how many have passed that examination.
tabling member printed	Baroness Cavendish of Little Venice
uin	HL6910
answer	answer is ministerial correction date of answer 06/04/2023 answer text <p>The information is not held in the format requested. The Nursing and Midwifery Council (NMC) is the independent regulator of nurses and midwives in the United Kingdom and nursing associates in England. It sets the standards that registrants must meet to demonstrate that they are capable of practising safely and effectively in those professions.</p><p> </p><p>Information on the number of professionals sitting and passing the Objective Structured Clinical Examination is published on the NMC’s website in an online-only format.</p> answering member printed Lord Markham question first answered 06/04/2023 11:37:23 answering member 4948 label Biography information for Lord Markham
tabling member	4578 label Biography information for Baroness Cavendish of Little Venice

1608434

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what (1) evidential basis, and (2) rationale, the Joint Committee on Vaccination and Immunisation used to determine that family members of, and carers for, people in the clinical risk groups identified in the Green Book are not recommended to receive COVID-19 booster vaccinations.
tabling member printed	Lord Mendelsohn
uin	HL6940
answer	answer is ministerial correction date of answer 12/04/2023 answer text <p>In November 2022, the Joint Committee on Vaccination and Immunisation (JCVI) provided interim advice which indicated that in autumn 2023, persons at higher risk of severe COVID-19 could be offered a booster vaccine dose in preparation for winter 2023 to 2024. As it was interim advice, the JCVI report does not contain any evidential basis for proposed cohorts. Final advice on who will be advised to receive COVID-19 boosters in autumn 2023 will be provided in due course. The considerations for any future decisions will be referenced in JCVI reports and meeting minutes.</p><p> </p><p>In February 2023, JCVI provided advice for the spring 2023 COVID-19 vaccination programme. As a precautionary measure, JCVI advised a spring booster dose for the most vulnerable in the population, as a proportionate response: those over the age of 75 years, residents in a care home for older adults, and those over five years of age who are immunosuppressed. These groups were chosen as they continue to be at highest risk of severe COVID-19.</p><p> </p> answering member printed Lord Markham question first answered 12/04/2023 13:31:48 answering member 4948 label Biography information for Lord Markham
tabling member	4286 label Biography information for Lord Mendelsohn

1608435

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, following the decision by the Joint Committee on Vaccination and Immunisation that family members of, and carers for, people in the clinical risk groups are not recommended to receive COVID-19 booster vaccinations, what steps they are taking to protect people in clinical risk groups from contracting COVID-19.
tabling member printed	Lord Mendelsohn
uin	HL6941
answer	answer is ministerial correction date of answer 12/04/2023 answer text <p>As set out in the Written Ministerial Statement titled ‘Approach to Managing Covid-19’ on 30 March 2023, in 2023/24 the Government will maintain a range of capabilities to protect those at higher risk of severe illness from COVID-19. Given the continued effectiveness of vaccines and improved treatments, for most people there is a much lower risk of severe illness compared to earlier in the pandemic.</p><p> </p><p>We will therefore continue to encourage people to take up the vaccines to which they are entitled, and we will continue to fund and provide COVID-19 testing, to manage outbreaks in some high-risk settings and to enable access to treatments for those who are eligible. We will also maintain essential COVID-19 surveillance activities in the community, primary and secondary care, and in high-risk settings. Additionally, we will retain proportionate capability for testing in the event of a COVID-19 wave or variant that results in a significant increase in pressure on the National Health Service.</p><p> </p><p>Vaccination does not significantly limit transmission, so there is no strong reason to prioritise vaccination for carers of those who are at high risk of severe illness.</p> answering member printed Lord Markham question first answered 12/04/2023 13:39:05 answering member 4948 label Biography information for Lord Markham
tabling member	4286 label Biography information for Lord Mendelsohn

1608436

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Joint Committee on Vaccination and Immunisation: Disclosure of Information
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether the minutes of the Joint Committee on Vaccination and Immunisation meeting that set out the clinical risk groups for the COVID-19 vaccination programme in Spring 2023 will be made available to the public.
tabling member printed	Lord Mendelsohn
uin	HL6942
answer	answer is ministerial correction date of answer 12/04/2023 answer text <p>The minutes of the meeting of the Joint Committee on Vaccination and Immunisation, which discussed which groups would be eligible for the precautionary COVID-19 booster programme of spring 2023, will be made publicly available through the GOV.UK website in due course.</p> answering member printed Lord Markham question first answered 12/04/2023 13:41:41 answering member 4948 label Biography information for Lord Markham
tabling member	4286 label Biography information for Lord Mendelsohn

1608437

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the statement by the Joint Committee on Vaccination and Immunisation COVID-19 vaccination programme for 2023: JCVI interim advice, 8 November 2022, what estimate they have made of the number of vaccinations required to prevent a COVID-19 hospital admission for individuals in clinical risk groups, as outlined in the Green Book; and whether they will provide a link to Appendix A of this statement.
tabling member printed	Lord Mendelsohn
uin	HL6943
answer	answer is ministerial correction date of answer 24/04/2023 answer text <p>The numbers needed to vaccinate (NNV) for the prevention of hospitalisation was calculated to consider the benefits of continued offers of primary vaccination, booster vaccination, the autumn booster and potential boosting in the spring of 2023, for example, for those newly entering a risk group. This calculation estimates the number of people in a particular group who would need to be vaccinated in order to prevent one hospitalisation. The lower the number, the more beneficial vaccination of that group would be.</p><p> </p><p>Strong age effects were seen, as well as large differences within adult ages, by clinical risk group. The oldest age groups and the older individuals in clinical risk groups had the lowest NNV for prevention of hospitalisation. There is also a trend for higher NNV for prevention of hospitalisation when moving from the primary to each booster dose.</p><p> </p><p>The spring 2023 booster is for immunosuppressed people at risk rather than all individuals in a clinical risk group.</p><p> </p><p>The results of NNV by age and clinical risk group are shown in Tables 3b and 4a of Appendix 1, which is attached.</p><p> </p><p>These cover all individuals in a risk group based on analysis of data including the national immunisation register. The NNV has not been broken down into separate clinical risk groups, as outlined in the Green Book.</p> answering member printed Lord Markham question first answered 24/04/2023 14:45:48 answering member 4948 label Biography information for Lord Markham attachment 1 file name Appendix 1_ estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation.pdf title Appendix 1: NNV to prevent hospitalisation
tabling member	4286 label Biography information for Lord Mendelsohn

1608438

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what are their reasons for implementing restrictions on the spring 2023 COVID-19 booster programme; and what factors were considered in determining the eligibility criteria for the booster programme.
tabling member printed	Lord Mendelsohn
uin	HL6944
answer	answer is ministerial correction date of answer 12/04/2023 answer text <p>As with all vaccination programmes in the United Kingdom, the decision on which groups are eligible for a particular vaccination programme is only made following careful consideration of the groups most at risk of illness, severe illness, or death because of infection. For COVID-19, the primary aim of the vaccination programme continues to be the prevention of severe disease, both in hospitalisation and mortality, arising from COVID-19.</p><p> </p><p>Therefore, in February 2023, the Joint Committee on Vaccination and Immunisation (JCVI) provided advice for the spring 2023 COVID-19 vaccination programme. As a precautionary measure, JCVI advised a spring booster dose for the most vulnerable in the population, as a proportionate response: those over the age of 75 years, residents in a care home for older adults, and those over five years of age who are immunosuppressed.</p> answering member printed Lord Markham question first answered 12/04/2023 13:33:00 answering member 4948 label Biography information for Lord Markham
tabling member	4286 label Biography information for Lord Mendelsohn

1608444

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Public Health: Finance
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what are the reasons for the delay in the publication of the Public Health Grant Allocation for 2023/24; and what assessment they have made of the impact of this delay on councils and their ability to plan effectively for the new financial year.
tabling member printed	Lord Storey
uin	HL6954
answer	answer is ministerial correction date of answer 30/03/2023 answer text <p>Local Authority Public Health Grant allocations are not required to be published by a specific date. The Public Health Grant allocations for 2023/24 were published on 14 March 2023. Publication dates for allocations in the three previous years were 17 March 2020, 16 March 2021, and 7 February 2022.</p><p> </p><p>In recognition of the need to offer local authorities as much certainty as possible, we have also published the indicative allocations for 2024/25 and aim to confirm these by the end of the calendar year.</p> answering member printed Lord Markham question first answered 30/03/2023 15:52:09 answering member 4948 label Biography information for Lord Markham
tabling member	4238 label Biography information for Lord Storey

1608456

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gonorrhoea
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to limit the spread of extensively antibiotic-resistant gonorrhoea (1) in the general population, (2) in vulnerable populations, and (3) among elderly populations.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL6904
answer	answer is ministerial correction date of answer 06/04/2023 answer text <p>The effectiveness of treatment for gonorrhoea continues to be threatened by the development of resistance to the last-line treatment, ceftriaxone. The UK Health Security Agency’s (UKHSA) Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) includes a suite of testing and surveillance systems to detect and monitor antimicrobial resistance in <em>Neisseria gonorrhoeae</em> and potential treatment failures. GRASP reports annually on drug resistance in <em>N. gonorrhoeae</em> in England and Wales and has directly influenced changes in treatment guidelines on three occasions.</p><p> </p><p>Additionally, all primary diagnostic laboratories test gonococcal isolates for susceptibility to ceftriaxone and refer suspected resistant isolates to the UKHSA national reference laboratory for confirmatory testing and follow-up in real-time. UKHSA has published guidance on managing cases of ceftriaxone-resistant gonorrhoea and performs a risk assessment for each case. If there is a risk of transmission within England, UKHSA instigates an Incident Response to contain spread.</p><p> </p><p>This applies to all population groups, including vulnerable and elderly populations, as the approach to tackling antibiotic-resistant gonorrhoea is universal across England.</p> answering member printed Lord Markham question first answered 06/04/2023 14:35:37 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle